Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-03-13
2007-03-13
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017400, C514S018700, C530S317000, C530S323000, C530S330000
Reexamination Certificate
active
10255679
ABSTRACT:
Cyclic to Synthetic pseudopeptide derivatives of osteogenic growth polypeptide (OGP) and OGP(10-14) which are capable of enhancing bone cell proliferation and bone formation. Pharmaceutical composition comprising as active ingredient at least one pseudopeptide derivative of the invention and to the use of these pseudopeptide derivatives in the preparation of a pharmaceutical composition for stimulating the formation of osteoblastic or fibroblastic cells, enhancing bone formation in osteopenic pathological conditions, repairing fractures, healing wounds, grafting of intraosseous implants, reversing bone loss in osteoporosis and other conditions requiring enhanced bone cells formation.
REFERENCES:
patent: 5461034 (1995-10-01), Rodan et al.
patent: A-0 384 731 (1990-08-01), None
patent: 572 122 (1993-12-01), None
patent: WO94/20529 (1994-09-01), None
Gazit D., et al. Regenerating marrow induces systemic increase in osteo- and chondrogenesis (1990) Endocrinology 126:2607-2613.
Mueller, M., et al. A systemic acceleratory phenomenon (SAP) accompanies the regional acceleratory phenomenon (rap) during healing of a bone defect in the rat (1991) J. Bone Min. Res. 6:401-410.
Bab, I., et al. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity (1992) EMBO J. 11:1867-1873.
Greenberg, Z., et al Structural and functional characterization of osteogenic Growth peptide from human serum: identity with rat and mouse homologs (1995) J. Clin. Endocrinol. Metab 80:2330-2335.
Morodor, L., et al (1976) Physiol. Chem. 357:1651.
Merrifield (1969) Adv. Enzymol. 32:221.
Stewart, J.M., Young, J.D., (1984) In: Solid Phase Peptide Synthesis. Pierce Chemical Co.: Rockford, IL, pp. 1-75.
Greenberg, Z., et al. Mitogenic action of osteogenic growth peptide (OGP): Role of amino and carboxy-terminal regions and charge (1993) Biochim Biophys Acta 1178:273-280.
Lender, A., et al Design and synthesis of sulfur-free cyclic hexapeptides which contain the rgd sequence and bind to the fibrinogen GP IIb/IIIa receptor (1993) Int. J. Peptide Protein Res., 42:509-517.
Nishino, N., et al Sequence dependence in solid-phase-synthesis cyclization cleavage for cyclo(-arginyl-glycyl-aspartyl-phenylglycyl-) (1992) Tetrahedron Letters, 33:1479-1482.
Cheung, S.T. and Benoiton, N.L., N-Methylamino acids in peptide synthesis V. The synthesis of N-tert-butyloxycarbonyl, N-methylamino acids by N-methylation (1977) Can. J. Chem., 55:906-.
Sasaki, Y. and Coy, D.H., Solid phase synthesis of peptides containing the CH2NH peptide bond isostere (1987) Peptides, 8:119-121.
Fehrentz, J.-A. and Castro B., An efficient synthesis of optically active α-(t-Butoxycarbonylamino)-aldehydes from α-amino acids (1983) Synthesis, pp. 676-678.
Hocart, S.J., et al Effect of the CH2NH and CH2NAc peptide bond isosteres on the antagonistic and histamine relating activities of a luteinizing hormone releasing hormone analogue (1988) J. Med. Chem. 31:1820-1824.
Wilchek, M. and Bayer, E.A., (1990) Methods Enzymol 184:5.
Rickard, D.J., et al (1994) Biology, 161:218.
Bab, I and Einhorn T.M. Polypeptide factors regulating osteogenesis and bone marrow repair (1994) J. Cellular Biochemistry 55:358-365.
Robinson I. et al. Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells (1995) J. of Bone and Min. Res. 10(5):690-696.
Bab. I. et. al. Regulatory role of osteogenic growth peptide in proliferation, osteogenesis and hemopoiesis (1995) Clinical Orthopaedics and Related Research 313:64-68.
Gurevitch O. et al. Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice (1996) Blood 88(12):4719-4724.
Bab I. Postablation bone marrow regeneration: anin vivomodel to study differential regulation of bone formation and resorption (1995) Bone 17(4):437S-441S.
Bab I. Regulatory role of osteogenic growth polypeptide in bone formation and hemopoiesis (1993) Critical Reviews in Eukaryotic Gene Expression 3(1):31-46.
Moroder, L. et al. et al., Hoppe Seylers Z. Physiol. Chem. 357(11): 1651-3 (Nov. 1976).
Rickard, D. J. et al., Dev. Biol. 161(1): 218-28 (Jan. 1994).
Bab I., et al. Removal of tibial marrow induces increased formation of bone and cartilage in rat mandibular condyle (1985) Calcif. Tissue Int. 37:551-555.
Foldes, J., et al. Osteogenic response to marrow aspiration: increased serum osteocalcin and alkaline phosphatase in human bone marrow donors (1989) J. Bone Min. Res. 4:643-647.
Einhorn, T.A., et al. The Osteogenic response to distant skeletal injury (1990) J. Bone Joint Surg. Am. 72:1374-1378.
Bab Itai
Chorev Michael
Gazit Dan
Muhlrad Andras
Shteyer Arie
Haddaway Keith G.
Kinberg Robert
Venable LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Synthetic peptides and pseudopeptides having osteogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptides and pseudopeptides having osteogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptides and pseudopeptides having osteogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3756463